Anthony Caggiano - Jul 29, 2025 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role
Chief Medical Officer
Signature
/s/ Lisa Ricciardi, Attorney-in-Fact
Stock symbol
CGTX
Transactions as of
Jul 29, 2025
Transactions value $
-$13,592
Form type
4
Date filed
7/31/2025, 04:24 PM
Previous filing
Feb 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Caggiano Anthony Chief Medical Officer C/O COGNITION THERAPEUTICS INC, 2403 SIDNEY STREET, SUITE 261, PITTSBURGH /s/ Lisa Ricciardi, Attorney-in-Fact 2025-07-31 0001892981

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGTX Common Stock Award $0 +65K +15.53% $0.00 484K Jul 29, 2025 Direct F1
transaction CGTX Common Stock Tax liability -$13.6K -20.3K -4.19% $0.67 463K Jul 29, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares earned upon the vesting of performance stock units ("PSUs") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. 50% of the total number of shares subject to the PSUs vested on July 29, 2025.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs.